Wanbury Ltd

WANBURY
Health CarePharmaceuticals
SmallcapWith a market cap of ₹224 cr, stock is ranked 1,565
High RiskStock is 3.12x as volatile as Nifty
68.852.30 (-3.23%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹224 cr, stock is ranked 1,565
High RiskStock is 3.12x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-17.85
PB RatioPB Ratio
-1.44
Dividend YieldDiv. Yield
Sector PESector PE
38.74
Sector PBSector PB
5.18
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Wanbury Limited is a pharmaceutical company which offers active pharmaceutical ingredient in over 70 countries.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021447.80400.70451.23394.92-32.00-24.8464.46-12.60
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 12.19%

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Financial Result Updates 
Announced OnNov 25, 2021

Wanbury Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

Wanbury Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

Outcome of Board Meeting 
Announced OnNov 25, 2021

Wanbury Limited has informed the Exchange regarding Board meeting held on November 25, 2021. | Download

Wanbury Limited has informed the Exchange regarding Board meeting held on November 25, 2021. | Download

Cash Dividend 
Ex. DateJul 29, 2010

Final • Div/Share: ₹ 1

See all events